Both the amount of equity financing and venture capital attracted by UK biotechs dropped in 2025, compounding concerns for the level of the country’s life science industry attractiveness on the international stage. As per a report from the BioIndustry Association (BIA), a UK-based trade association, equity financing and venture capital dropped 49% and 13%, respectively, in 2025 compared to 2024. While the amount of biotech funding is down globally, concerns about the UK’s capital flow are heightened due t ...